Other Event

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event

Ignite Creation Date: 2025-12-25 @ 2:39 AM
Ignite Modification Date: 2025-12-26 @ 1:17 AM
NCT ID: NCT05596734
Term: Myalgia (MUSCLE PAIN)
Organ System: Musculoskeletal and connective tissue disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA v26.1
Notes: None
Study: NCT05596734
Study Brief: A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and Influenza
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG000 None 14 30 View
EG001 None 9 28 View
EG002 None 10 30 View
EG003 None 5 30 View
EG004 None 5 30 View
EG005 None 11 32 View
EG006 None 8 33 View
EG007 None 4 32 View
EG008 None 12 33 View
EG009 None 5 33 View
EG010 None 8 33 View
EG011 None 0 33 View
EG012 None 6 29 View
EG013 None 8 32 View
EG014 None 45 124 View
EG015 None 45 122 View
EG016 None 38 114 View
EG017 None 17 31 View
EG018 None 7 30 View
EG019 None 11 33 View
EG020 None 10 30 View
EG021 None 8 26 View
EG022 None 13 32 View
EG023 None 4 29 View